Archive · 10 Aug 2025
Indegene CTO: Strong Guardrails for Pharma GenAI Success
Indegene, a company that works with drug companies, is using fancy computer programs called GenAI to help them.
This helps them make medicines and sell them.
A big boss at Indegene says they need to be careful and set rules to make sure the GenAI is used in the right way.
They're also training their employees to use this technology.
They see two main ideas happening: one where computers talk to us in a natural way, and another where computers can research complicated problems.
This should help drug companies make better medicines and sell them faster.
Indegene, a healthtech company, is developing GenAI capabilities for pharma.
The company aims to help pharma companies deliver drugs faster and reduce sales costs.
CTO Tarun Mathur discusses scaling GenAI and addressing industry challenges.
Governance is crucial for responsible GenAI use, setting standards for models and frameworks.
Two trends are noted: conversational GenAI and deep research-enabled agents.
- Who
- Tarun Mathur, CTO of Indegene, and the company itself.
- What
- Indegene is developing and using GenAI for the pharmaceutical industry.
- When
- Q1FY26 and onwards
- Where
- Bengaluru
- Why
- To help pharma companies deliver drugs faster, lower costs, and improve processes.
Industry Needs
Key Challenges
Responsible GenAI use
Industry Needs
Needs systems for transparency, data privacy, and fairness.
Key Challenges
Needs to mitigate risks, establish trust, and employ robust guardrails.
- Company
- Indegene
- Location
- Bengaluru
- Focus
- Life sciences domain
- Revenue Q1FY26
- Rs 760.8 crore
- Revenue Q1FY25
- Rs 676.5 crore
- Key initiative
- GenAI@Work